What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Enzyme
His main research concerns Internal medicine, Genotype, Cancer research, Genetics and Endocrinology.
His studies in Internal medicine integrate themes in fields like Gastroenterology and Biochemistry.
His research in Genotype intersects with topics in Immunology and Allele.
Fuu Jen Tsai has included themes like Endometriosis and Molecular biology in his Allele study.
His Cancer research research integrates issues from PI3K/AKT/mTOR pathway, Apoptosis, Protein kinase B, Signal transduction and Carcinogenesis.
His Endocrinology study integrates concerns from other disciplines, such as Genetic marker, Receptor and Cytochrome c.
His most cited work include:
- Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. (744 citations)
- IKKβ Suppression of TSC1 Links Inflammation and Tumor Angiogenesis via the mTOR Pathway (511 citations)
- ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation (496 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Internal medicine, Genetics, Genotype, Endocrinology and Allele.
The various areas that Fuu Jen Tsai examines in his Internal medicine study include Gastroenterology, Polymorphism, Diabetes mellitus and Oncology.
His Genetics study frequently involves adjacent topics like Molecular biology.
His Immunology research extends to the thematically linked field of Genotype.
Endocrinology is often connected to Apoptosis in his work.
His study ties his expertise on Genetic marker together with the subject of Allele.
He most often published in these fields:
- Internal medicine (36.55%)
- Genetics (24.14%)
- Genotype (22.16%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (36.55%)
- Cancer research (10.60%)
- Type 2 diabetes (5.17%)
In recent papers he was focusing on the following fields of study:
Fuu Jen Tsai spends much of his time researching Internal medicine, Cancer research, Type 2 diabetes, Endocrinology and Apoptosis.
His Internal medicine research incorporates elements of Diabetes mellitus, Diabetic retinopathy and Single-nucleotide polymorphism.
His Single-nucleotide polymorphism study introduces a deeper knowledge of Genotype.
His Cancer research research includes themes of Cancer cell, Cancer, Metastasis, Protein kinase B and Cell.
As part of his studies on Endocrinology, Fuu Jen Tsai often connects relevant areas like Allele.
Fuu Jen Tsai interconnects Cell growth and Cell biology in the investigation of issues within Apoptosis.
Between 2015 and 2021, his most popular works were:
- Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function (273 citations)
- Resveratrol-induced autophagy and apoptosis in cisplatin-resistant human oral cancer CAR cells: A key role of AMPK and Akt/mTOR signaling (75 citations)
- Genome-wide association studies in East Asians identify new loci for waist-hip ratio and waist circumference. (47 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Enzyme
Fuu Jen Tsai mostly deals with Internal medicine, Cancer research, Apoptosis, Cell biology and Diabetes mellitus.
The concepts of his Internal medicine study are interwoven with issues in Gastroenterology, Endocrinology and Hyperlipidemia.
His research integrates issues of Cancer cell, Cancer, Metastasis, Protein kinase B and Cell cycle checkpoint in his study of Cancer research.
His Cell biology study incorporates themes from Molecular biology, SAP30, DNA fragmentation and Cerebroside.
Many of his research projects under Diabetes mellitus are closely connected to Polyol pathway with Polyol pathway, tying the diverse disciplines of science together.
His Kidney research is within the category of Genetics.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
